KORRO BIO ($KRRO) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$2.74 per share, missing estimates of -$2.62 by $0.12. The company also reported revenue of $1,460,000, beating estimates of $518,802 by $941,198.
You can see Quiver Quantitative's $KRRO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KORRO BIO Hedge Fund Activity
We have seen 32 institutional investors add shares of KORRO BIO stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORMORANT ASSET MANAGEMENT, LP added 380,303 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,621,075
- POLAR CAPITAL HOLDINGS PLC added 175,000 shares (+233.3%) to their portfolio in Q1 2025, for an estimated $3,046,750
- BLUE OWL CAPITAL HOLDINGS LP added 125,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,561,250
- EVENTIDE ASSET MANAGEMENT, LLC removed 117,556 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,046,649
- CITADEL ADVISORS LLC removed 116,483 shares (-31.5%) from their portfolio in Q1 2025, for an estimated $2,027,969
- FRANKLIN RESOURCES INC removed 91,704 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,145,382
- DRIEHAUS CAPITAL MANAGEMENT LLC added 87,544 shares (+17.7%) to their portfolio in Q1 2025, for an estimated $1,524,141
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KORRO BIO Analyst Ratings
Wall Street analysts have issued reports on $KRRO in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 07/24/2025
- Chardan Capital issued a "Buy" rating on 05/13/2025
- Oppenheimer issued a "Outperform" rating on 05/13/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/29/2025
- RBC Capital issued a "Outperform" rating on 03/19/2025
To track analyst ratings and price targets for KORRO BIO, check out Quiver Quantitative's $KRRO forecast page.
KORRO BIO Price Targets
Multiple analysts have issued price targets for $KRRO recently. We have seen 5 analysts offer price targets for $KRRO in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Mitchell Kapoor from HC Wainwright & Co. set a target price of $100.0 on 07/24/2025
- Keay Nakae from Chardan Capital set a target price of $25.0 on 05/13/2025
- Andreas Argyrides from Oppenheimer set a target price of $90.0 on 05/13/2025
- Steven Seedhouse from Cantor Fitzgerald set a target price of $74.0 on 04/29/2025
- Luca Issi from RBC Capital set a target price of $95.0 on 03/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
